Tasigna Lawyer | Free Attorney Consultation for Tasigna Lawsuits
National Tasigna Lawyers Provide Information About Tasigna Circulatory Problems Claims
Tasigna (nilotinib) is one of the ten most popular cancer treatment drugs in the world, used to treat Philadelphia chromosome-positive chronic myeloid leukemia (Ph+CML). Medical research has shown that Tasigna usage leads to the disease Atherosclerosis, the narrowing and hardening of the arties due to build-up of plaque and white blood cells. A 2011 medical report showed that 25% of Tasigna users suggered from vascular problems and 16% of Tasigna users suffered from Peripheral Arterial Disease.
Onder Law's Tasigna Lawyers are handling cases against the maker of Tasigna not because Tasigna caused atherosclerosis, but because the drug's maker knew that it could cause atherosclerosis and lead to even graver health complications, such as amputation of the legs, and then not only chose to not disclose that risk to American Tasigna users, but then engaged in illegal activity so that more Americans would use Tasigna.
What Are the Dangers of Atherosclerosis?
Death, heart attack, stroke, coronary artery disease, peripheral arterial disease, potentially leading to amputation of one or more limbs. Tasigna atherosclerosis has been found to both occur rapidly and severely.
Why Should I Consult with a Tasigna Lawyer?
Money can't suddenly reverse atherosclerosis, a heart attack or stroke, and certainly can't bring back a relative. It can pay for medical expenses and, unfortunately, is often the only way to ssend drug companies a message to stop putting profits before patients. Read our Tasigna Lawsuit FAQs for answers to most questions about Tasigna lawsuits. Our Tasigna Lawsuit page gives more details about what you can expect from making a claim against the maker of Tasigna.
Tasigna Maker Has History of Illegal Activity
Tasigna is made and marketed by Novartis AG Pharmaceutical. Based in Switzerland, Novartis is one of the multi-national corporations that make up Big Pharma. The company did just over $50 billion in total sales in 2015, and its corporate history shows that Novartis has been willing to overstep the law in order to increase sales. Since 2010, Novartis has paid the US Department of Justice over $800 million tosettle both criminal and civil charges. Furthermore, Novartis has paid similar fines in other countries as a result of illegal pharmaceutical marketing.
2015: Novartis Pays $390 Million in Fines Relating to Tasigna
The United States Department of Justice charged Novartis with paying specialty pharmacies illegal kickbacks to get them to recommend Novartis drugs to persons using Medicaid and Medicare to fill prescriptions for six different Novartis drugs, including Tasigna. Four years after Novartis was fully aware of the Tasigna atherosclerosis risk, after it had changed the Tasigna product packaging to warn Canadian Tasigna users of atherosclerosis, Novartis was so intent on earning hundreds of millions of dollars more from Tasigna that it engaged in illegal activity. The federal lawsuit against Novartis included Tasigna and five other drugs.
No Fees Unless We Collect for You - Contingency Representation for Tasigna Atherosclerosis Claims
The Onder Law Firm will represent all persons involved in a Tasigna lawsuit on a contingency basis, meaning there are never any legal fees unless we win compensation in your case. For a free no-obligation consultation please fill out our short online contact form or call us at 1-877-ONDER-LAW and one of our attorneys handling Tasigna lawsuits will contact you to answer any of your questions.
The Onder Law Firm is a St. Louis based law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. Onder Law has represented clients throughout the United States, and other firms throughout the nation often seek its experience and expertise on complex litigation. It is a recognized leader in products liability cases such as window blind cord strangulation and pharmaceutical litigation, such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $1.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won $197 million in three talcum powder ovarian cancer lawsuits in St. Louis in 2016 and other law firms throughout the nation often seek its experience and expertise on complex litigation.
Onder Law Has Been Covered By: